Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54,347,826
-
Total 13F shares
-
46,709,070
-
Share change
-
+5,464,878
-
Total reported value
-
$813,618,424
-
Price per share
-
$17.42
-
Number of holders
-
84
-
Value change
-
+$75,118,533
-
Number of buys
-
55
-
Number of sells
-
31
Institutional Holders of Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) as of Q4 2024
As of 31 Dec 2024 Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,709,070 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Red Tree Management, LLC, TPG GP A, LLC, Omega Fund Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BRAIDWELL LP, Deep Track Capital, LP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This table shows 84 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.